Martinovich KM, Shaw NC, Kicic A, Schultz A, Fletcher S, Wilton SD, and Stick SM, The potential of antisense oligonucleotide therapies for inherited childhood lung diseases. Mol Cell Pediatr, 2018. 5(1): p. 3.

Flynn LL, Mitrpant C, Pitout IL, Fletcher S, and Wilton SD, Antisense oligonucleotide mediated terminal intron retention of the SMN2 transcript. Mol Ther Nucleic Acids, 2018. (in press).

Martinovich KM, Shaw NC, Kicic A, Schultz A, Fletcher S, Wilton SD, and Stick SM, The potential of antisense oligonucleotide therapies for inherited childhood lung diseases. Mol Cell Pediatr, 2018. 5(1): p. 3.

Rational design of short locked nucleic acid-modified 2’-O-methyl antisense oligonucleotides for efficient exon-skipping in vitro. Le BT, Adams AM, Fletcher S, Wilton SD, and Veedu RN (2017) Molecular Therapy Nucleic Acids, 9, 155–161. doi: 10.1016/j.omtn.2017.09.002

A common dominant-negative COL6A1 pseudo-exon insertion is skippable using splice-modulating oligonucleotides Bolduc V, Foley A, Donkervoort S, Hu Y, Cummings B, Lek M, Sarathy A, Sizov K, Degefa H, Wagener R, Hennig G, Hanssen E, Lamande S, Muntoni F, Wilton SD, Macarthur DG, Bonnemann C 2017 Neuromuscular Disorders 27: S177-S177

Le BT, Adams AM, Fletcher S, Wilton SD, and Veedu RN (2017) Rational design of short locked nucleic acid-modified 2’-O-methyl antisense oligonucleotides for efficient exon-skipping in vitro. Molecular Therapy – Nucleic Acids, 9, 155–161. doi: 10.1016/j.omtn.2017.09.002 [Rank: Q1; Cell Press]

Comprehending the Health Informatics Spectrum: Grappling with System Entropy and Advancing Quality Clinical Research Bellgard MI, Chartres N, Watts GF, Wilton SD, Fletcher S, Hunter A, Snelling T 2017 Front Public Health 5: 224

Rational Design of Short Locked Nucleic Acid-Modified 2′-O-Methyl Antisense Oligonucleotides for Efficient Exon-Skipping In Vitro Le BT, Adams AM, Fletcher S, Wilton SD and Veedu RN 2017 Mol Ther Nucleic Acids 9: 155-161

Inherited retinal disease therapy targeting precursor messenger ribonucleic acid Huang D, Fletcher S, Wilton SD, McLenachan S, Mackey DA, Chen FKVision (2017) in press

Efficient Skipping of Single Exon Duplications in DMD Patient-Derived Cell Lines Using an Antisense Oligonucleotide Approach Wein N, Vulin A, Findlay AR, Gumienny F, Huang N, Wilton SD, Flanigan KM 2017 Journal Neuromuscul Dis 4: 199-207